New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareNonapeptide-1 vs MGF (Mechano Growth Factor)

Nonapeptide-1 vs MGF (Mechano Growth Factor)

Side-by-side comparison of key properties, dosing, and research.

Skin & Cosmetic
Nonapeptide-1
Anabolic & IGF
MGF (Mechano Growth Factor)
Summary
Nonapeptide-1 is a synthetic 9-amino acid peptide that inhibits melanin production by blocking α-MSH (alpha-melanocyte stimulating hormone) receptor binding. Used in cosmetic formulations for skin lightening and evening skin tone, it is particularly effective for UV-induced and hormonal hyperpigmentation.
MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is locally produced in muscle tissue in response to mechanical damage from exercise. It activates muscle satellite cells (stem cells) to proliferate and repair damaged fibers, making it specifically targeted at exercise-induced hypertrophy.
Half-Life
Not applicable (topical)
Native MGF: minutes. PEG-MGF: ~3 days
Admin Route
Topical
SubQ, IM
Research
Typical Dose
0.05–0.5% concentration in formulation
200–400 mcg
Frequency
Twice daily
1–2 times per week
Key Benefits
  • Inhibits UV-induced tanning and hyperpigmentation
  • Reduces hormonal melasma
  • Evens skin tone at receptor level
  • Well-tolerated with minimal irritation
  • Complementary to tyrosinase inhibitors for enhanced brightening
  • Reduces post-inflammatory hyperpigmentation
  • Activates muscle satellite cells for repair and growth
  • Accelerates recovery from muscle damage
  • Synergistic with IGF-1 LR3 (different mechanisms)
  • Promotes muscle hypertrophy specifically at exercised muscles
  • Faster recovery between training sessions
  • Potential for injury repair in connective tissue
Side Effects
  • Generally very well-tolerated
  • Rare contact sensitivity in susceptible individuals
  • Theoretical risk of excessive depigmentation with prolonged high-concentration use
  • Muscle soreness (satellite cell activation)
  • Injection site irritation
  • Hypoglycemia risk (modest, less than IGF-1 LR3)
Stacks With